Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clinical trials with polymer platinate AP-5280 to begin

Sep. 14, 2000

New leads in the search for next-generation microtubule-directed taxoids

Sep. 14, 2000

Telomerase immunization induces antitumor response

Sep. 14, 2000

Phase I clinical trials of Xcytrin begin for treatment of NSCLC and glioblastoma multiforme

Sep. 13, 2000

Priority review granted to Femara as first-line breast cancer therapy

Sep. 13, 2000

Synthesis and activity of novel PTK inhibitors reported by U.S. university researchers

Sep. 13, 2000

SRI presents novel steroid mimics useful for breast cancer

Sep. 13, 2000

BASF grants exclusive licenses for oncolytic compounds to Ilex

Sep. 13, 2000

Kyowa Hakko reports new series of proteasome inhibitors

Sep. 12, 2000

Novel inhibitors of tyrosine kinase from Merck useful for angiogenesis-related disorders

Sep. 12, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...